Expression of Icsbp is decreased in human CML and re-expression of Icsbp in Bcr-abl+ bone marrow delays progression of CML in a murine transplant model [10, 11]. Here, IRF8 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.